EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Retained Earnings

Annual Retained Earnings:

-$378.58M-$133.81M(-54.67%)
December 31, 2024

Summary

  • As of today, EWTX annual retained earnings is -$378.58 million, with the most recent change of -$133.81 million (-54.67%) on December 31, 2024.
  • During the last 3 years, EWTX annual retained earnings has fallen by -$301.62 million (-391.91%).
  • EWTX annual retained earnings is now -2123.78% below its all-time high of -$17.02 million, reached on December 31, 2019.

Performance

EWTX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Quarterly Retained Earnings:

-$455.49M-$36.12M(-8.61%)
June 30, 2025

Summary

  • As of today, EWTX quarterly retained earnings is -$455.49 million, with the most recent change of -$36.12 million (-8.61%) on June 30, 2025.
  • Over the past year, EWTX quarterly retained earnings has dropped by -$150.70 million (-49.45%).
  • EWTX quarterly retained earnings is now -1233.91% below its all-time high of -$34.15 million, reached on December 31, 2020.

Performance

EWTX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

EWTX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-54.7%-49.5%
3Y3 Years-391.9%-323.0%
5Y5 Years-2123.8%-

EWTX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-391.9%at low-263.9%at low
5Y5-Year-2123.8%at low-1233.9%at low
All-TimeAll-Time-2123.8%at low-1233.9%at low

EWTX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$455.49M(-8.6%)
Mar 2025
-
-$419.37M(-10.8%)
Dec 2024
-$378.58M(-54.7%)
-$378.58M(-11.7%)
Sep 2024
-
-$338.91M(-11.2%)
Jun 2024
-
-$304.79M(-11.5%)
Mar 2024
-
-$273.29M(-11.7%)
Dec 2023
-$244.76M(-69.3%)
-$244.76M(-14.0%)
Sep 2023
-
-$214.62M(-13.6%)
Jun 2023
-
-$188.91M(-12.8%)
Mar 2023
-
-$167.44M(-15.8%)
DateAnnualQuarterly
Dec 2022
-$144.60M(-87.9%)
-$144.60M(-15.5%)
Sep 2022
-
-$125.19M(-16.2%)
Jun 2022
-
-$107.69M(-17.5%)
Mar 2022
-
-$91.62M(-19.0%)
Dec 2021
-$76.96M(-125.4%)
-$76.96M(-19.8%)
Sep 2021
-
-$64.26M(-25.2%)
Jun 2021
-
-$51.31M(-25.3%)
Mar 2021
-
-$40.96M(-20.0%)
Dec 2020
-$34.15M(-100.6%)
-$34.15M
Dec 2019
-$17.02M
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Edgewise Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of EWTX is -$378.58M

What is the all-time high annual retained earnings for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual retained earnings is -$17.02M

What is Edgewise Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, EWTX annual retained earnings has changed by -$133.81M (-54.67%)

What is Edgewise Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of EWTX is -$455.49M

What is the all-time high quarterly retained earnings for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly retained earnings is -$34.15M

What is Edgewise Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, EWTX quarterly retained earnings has changed by -$150.70M (-49.45%)
On this page